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A B S T R A C T
Objective: To summarize published studies on the prevalence of and risk factors for maternal bacterial
colonization and/or infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae
(ESBL-E) in pregnant and/or post-partum women in Africa.
Methods: A systematic review was conducted using the PubMed, Scopus, and Google Scholar databases.
Bibliographies of included eligible studies were manually searched to identify additional relevant
articles. No language restriction was applied. The timeframe of the search included all records from
electronic database inception to July 15, 2017. A random-effects meta-analysis was performed to
summarize the prevalence and the 95% conﬁdence intervals (CI) of ESBL-E colonization or infection in
pregnant or post-partum women in Africa. The meta-analysis was conducted using STATA IC 13.1
software and the metaprop function/plugin.
Results: Ten studies (seven on pregnant women and three on post-partum women) were included,
documenting a 17% prevalence of maternal colonization with ESBL-E in Africa (95% CI 10–23%). The
prevalence of ESBL-E in community isolates exceeded that in isolates from the hospital setting (22% vs.
14%). The most frequently reported ESBL-encoding gene was CTX-M (cefotaxime hydrolyzing
capabilities). Data on risk factors for maternal ESBL-E colonization and infection are very limited.
Conclusions: The prevalence of colonization and/or infection with ESBL-E in pregnant and post-partum
women in Africa exceeds that reported from high- and middle-income settings, representing a risk for
subsequent neonatal colonization and/or infection with ESBL-E.
© 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Antimicrobial resistance (AMR) is a growing threat to human
health globally (WHO, 2014; Frieden, 2013). A major mechanism of
AMR is the production of extended-spectrum beta-lactamase
(ESBL) enzymes, which confer resistance to penicillins, cepha-
losporins, and monobactams, but not to cephamycins and
carbapenems (Paterson and Bonomo, 2005; Pitout et al., 2005),
leaving limited therapeutic options for AMR infections. In 2013, the* Corresponding author at: Division of Health Systems and Public Health,
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).US Centers for Disease Control and Prevention (CDC) identiﬁed
ESBL-producing Enterobacteriaceae (ESBL-E) as a serious threat
(Frieden, 2013). In addition, the World Health Organization (WHO)
has published a priority pathogens list, and resistant ESBL-E are
classiﬁed as ‘critical’, priority number 1 (WHO, 2017).
ESBL- E occur worldwide in both community and hospital
settings (Paterson and Bonomo, 2005; Pitout et al., 2005; Sonda
et al., 2016; Storberg, 2014; Luvsansharav et al., 2011), and the
reported incidence of infections in paediatric and neonatal
populations is increasing (Paterson and Bonomo, 2005; Sonda
et al., 2016; Storberg, 2014; Flokas et al., 2017; Peirano and Pitout,
2010; Tansarli et al., 2014; Dramowski et al., 2015; Logan et al.,
2014). Clinical infections with ESBL-E are associated with increased
morbidity (including prolonged hospital stay), increased health-
care costs, and higher mortality rates compared to infections with
non-ESBL-E (Blomberg et al., 2005; Zaoutis et al., 2005; Kim et al.,ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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post-partum women, ESBL-E are frequently implicated in urinary
tract infections (UTI) (Pitout et al., 2005; Peirano and Pitout, 2010)
and bloodstream infections (BSI) (Luvsansharav et al., 2011; Flokas
et al., 2017; Dramowski et al., 2015; Zaoutis et al., 2005; Loh and
Sivalingam., 2007). Among neonatal ESBL-E infections, Klebsiella
pneumoniae and Escherichia coli are the most frequently isolated
species (Flokas et al., 2017; Dramowski et al., 2015; Zaidi et al.,
2005).
Well-established risk factors for early-onset neonatal sepsis
include maternal infections (e.g. UTIs and chorioamnionitis) and
prolonged rupture of the membranes (Chan et al., 2013; Chan et al.,
2015). In a well-powered systematic review, additional risk factors
identiﬁed were maternal bacterial colonization of the vaginal tract
(Chan et al., 2013; Chan et al., 2015) and poor antenatal care
(deﬁned as less than four antenatal visits per pregnancy)
(Mizumoto et al., 2015; Lincetto et al., 2006).
Although ESBL-E are well-documented as important blood-
stream pathogens in several African settings (Flokas et al., 2017;
Kim et al., 2002; Kang et al., 2004; Schiappa et al., 1996), little is
known about the determinants and magnitude of maternal
colonization with ESBL-E. Factors contributing to the development
of AMR (including ESBL-E) in Africa include socio-economic
challenges and health-associated factors (Kariuki and Dougan,
2014) (suboptimal hygiene and sanitation (Toole et al., 1995), weak
health systems (Essack et al., 2016), lack of laboratory capacity
(Okeke et al., 1999), and misuse of and easy access to antibiotics
(Okeke et al., 1999)). A high burden of immunocompromised
patients (HIV infection (Emacar et al., 2010) and diabetesTable 1
Characteristics of studies included in the review.
Number Author and year
of publication
Country Study
design
Clinical
samples
Population Nu
ES
1 Olufunke et al.
(2014)
Nigeria Cross-
sectional
Urine Pregnant
women
69
2 Onwuezobe
(2015)
Nigeria Cross-
sectional
Urine Pregnant
women
16
3 Chereau et al.
(2015)
Madagascar Cross-
sectional
Stool Pregnant
women
66
4 Nelson et al.
(2014)
Tanzania Cross-
sectional
Stool Post-
partum
women
16
5 Kaba et al.
(2016)
South Africa Cross-
sectional
Stool Post-
partum
women
4/
6 Sáez-lópez et al.
(2016)
Mozambique Cross-
sectional
Vaginal
swabs
Pregnant
women
1/
7 Djuikoue (2016) Cameroon Cross-
sectional
Stool Pregnant
women
15
8 Fortini et al.
(2015)
Nigeria Cross-
sectional
Stool Pregnant
women
32
9 Bebell et al.
(2017)
Uganda Prospective
cohort
Urine
Blood
Post-
partum
women
8/
10 Tito et al. (2017) Tanzania Cross-
sectional
Urine Pregnant
women
4/
ESBL-E, extended-spectrum beta-lactamase-producing Enterobacteriaceae.(Ntirenganya et al., 2015)), environmental contamination (Dusé,
2005), and inadequate decontamination of medical devices (Dusé,
2005), are other important factors exacerbating AMR pathogen
transmission in Africa. The relationship between these factors and
maternal colonization or infection with ESBL-E is unclear and
requires investigation.
This systematic review and meta-analysis summarizes the
magnitude of colonization or infection with ESBL-E among
pregnant and post-partum women in Africa and the associated
risk factors. Knowledge of the burden and risk factors of maternal
colonization or infection with ESBL-E will assist with clinical care,
infection prevention, and antibiotic stewardship, and inform the
future development of targeted interventions to reduce both
maternal and neonatal ESBL-E-associated morbidity and mortality.
Methods
Literature search
A systematic review was conducted in PubMed, Scopus, and
Google Scholar. The search strategy included the following words,
medical subject heading (MeSH) terms, and Boolean operators:
“(enterobacteriaceae OR bacteria OR resistant OR resistance OR
‘non-susceptible’ OR “non susceptible” OR “not susceptible”) AND
(coloni* OR infect* OR carri*) AND ((Africa OR Algeria OR Angola OR
Benin OR Botswana OR Burkina Faso OR Burundi OR Cabo Verde OR
Cameroon OR Central African Republic OR Chad OR Comoros OR
Democratic Republic of the Congo OR Republic of the Congo OR
Cote d’Ivoire OR Djibouti OR Egypt OR Equatorial Guinea OR Eritreamber of participants colonized with
BL-E/Total participants (% colonized)
ESBL-E species included
(isolate) and proportion
Setting
/264 (26.1%) Escherichia coli 69/264 Hospital
/80 (20%) Klebsiella pneumoniae 8/
16
Escherichia coli 6/16
Klebsiella oxytoca 1/16
Enterobacter cloacae 1/16
Community
/356 (18.6%) Escherichia coli 46/66
Klebsiella pneumoniae 11/
66
Enterobacter cloacae 5/66
Citrobacter freundii 3/66
Morganella morganii 1/66
Community
/113 (15%) Escherichia coli 6/20
Enterobacter spp 3/20
Klebsiella pneumoniae 1/
20
Citrobacter spp 2/20
Pantoea spp 3/20
Proteus spp 1/20
Hospital
90 (4.4%) Klebsiella pneumoniae 2/
90
Escherichia coli 1/90
Enterobacter cloacae 1/90
Community
51 (1.9%) Escherichia coli 1/51 Hospital
/26 (57.7%) Escherichia coli 15/26 Community
/101 (31.7%) Escherichia coli 32/101 Hospital
174 (4.6%) Escherichia coli 5/174
Klebsiella pneumoniae 3/
174
Hospital
49 (8.2%) Escherichia coli 4/49 Hospital
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Bissau OR Kenya OR Lesotho OR Liberia OR Libya OR Madagascar
OR Malawi OR Mali OR Mauritania OR Mauritius OR Morocco OR
Mozambique OR Namibia OR Niger OR Nigeria OR Rwanda OR “Sao
Tome and Principe” OR Senegal OR Seychelles OR Sierra Leone OR
Somalia OR South Africa OR South Sudan OR Sudan OR Swaziland
OR Tanzania OR Togo OR Tunisia OR Uganda OR Zambia OR
Zimbabwe)) AND (ESBL OR extended-spectrum-beta-lactamase OR
extended-spectrum-b-lactamase OR extended spectrum beta
lactamase) AND ((pregnant OR pregnancy OR gestation OR post-
delivery OR postdelivery OR “post delivery” OR post-part* OR
postpartum OR “post partum” OR perinatal OR antenatal OR
prenatal OR women))”. Bibliographies of eligible studies were
manually searched to identify additional relevant articles. It was
attempted to contact the authors of relevant studies to obtain
speciﬁc details. Following the screening of publications, a total of
10 articles were included (Table 1).
Study selection and eligibility criteria
All publications describing colonization and/or infection with
ESBL-E in pregnant or post-partum African women in both
community and hospital settings were selected, irrespective of
the study design. Primary study designs reporting the proportion
or prevalence of ESBL-E in pregnant or post-partum women, as
well as risk factors, were eligible. No language restriction was
applied. The timeframe of the search included all records from
electronic database inception to July 15, 2017. The article selection
and exclusion process is shown in Figure 1.Figure 1. Flow diagramData extraction
A data extraction form was designed to capture the following
information: ﬁrst author and year of publication; country; study
design (any type); study setting (community or hospital); study
population; number and percentage of women colonized or
infected with ESBL-E; total number of women recruited into the
study; ESBL-E isolates and their proportions; molecular identiﬁ-
cation of ESBL-E isolates (if performed); factors associated with
ESBL-E colonization or infection in women.
Data synthesis
A random-effects meta-analysis was performed to summarize
the proportions and the 95% conﬁdence intervals (CI) of ESBL-E in
pregnant or post-partum women in Africa. To ensure proportionate
weight distribution to studies presenting extreme prevalence
(near 0 or 1), the Freeman–Tukey arcsine methodology was applied
(Nyaga et al., 2014). The between-study heterogeneity was
assessed using the I2 statistic (which quantiﬁes the percentage
of variation across studies due to heterogeneity rather than to
chance): I2 <75% was considered as moderate heterogeneity
(Higgins and Thompson, 2002) and >75% reﬂected high heteroge-
neity, in which case subset analyses were performed. The random-
effects model was chosen based on the anticipated assumption
that studies reporting on the magnitude of ESBL-E in pregnant and
post-partum women used different laboratory methods, were
conducted in different settings (hospital and community), or had
other unknown factors inﬂuencing the magnitude of ESBL-E in of study selection.
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was performed using STATA IC version 13.1 software and the
metaprop function/plugin, which is a speciﬁc STATA program
designed for the meta-analysis of binomial data, allowing pooling
of proportions (Nyaga et al., 2014). A total of 1304 participants
were pooled from the studies included (927 pregnant women and
377 post-partum women).
Reporting of the meta-analysis of observational studies
This meta-analysis of observational studies is reported in
compliance with the MOOSE statement and checklist (Stroup et al.,
2000) (Meta-analysis of Observational Studies in Epidemiology).
Assessment of bias
The Newcastle–Ottawa Scale (Herzog et al., 2013) adapted for
cross-sectional studies (see below) was used to assess the risk of
bias for each selected study. This scale includes an evaluation ofTable 2
Risk of bias assessment for studies included in the quantitative synthesis (all observat
Author and
year of
publication
Selection 
Representativeness of the sample Ascertainment of exposure 
Olufunke
et al.
(2014)
*Truly representative of average
pregnant women with ESBL
Enterobacteriaceae
*Pregnant women diagnosed 
clinical isolates producing ESB
DDST
Onwuezobe
(2015)
*Truly representative of average
pregnant women with ESBL
Enterobacteriaceae
**Pregnant women diagnosed
clinical isolates producing ESB
DDST
Kaba et al.
(2016)
*Truly representative of post-partum
women with ESBL Enterobacteriaceae in
the community
**ESBL production was conﬁrm
using the combination disc te
Chereau
et al.
(2015)
*Truly representative of pregnant
women with ESBL Enterobacteriaceae in
the community
**Production of ESBL in ESC-re
Enterobacteriaceae was conﬁrm
DDST (CASFM)
Nelson et al.
(2014)
*Truly representative of post-partum
women with ESBL Enterobacteriaceae in
the hospital
*Rectal swabs plated onto
MacConkey agar (OXOID,
Basingstoke, UK) supplemente
cefotaxime 2 mg/l for prelimin
screening of ESBL bacterial iso
Sáez-lópez
et al.
(2016)
No description of participant selection **ESBL producers were identi
DDST using CTX, AMC and CA
Djuikoue
et al.
(2016a,b)
*Truly representative of outpatient
women consulting for a suspicion of
UTI, during the study period
**The presence of ESBL was
determined using the double 
diffusion phenotypic method
Fortini et al.
(2015)
*Truly representative of healthy
pregnant women on the day of
admission to hospital in Ibadan
(Nigeria)
**Phenotypic and genotypic
characterization of ESBL prod
Tito et al.
(2017)
*Truly representative of HIV-positive
pregnant women attending the PMTCT
clinics; all consenting HIV-positive
pregnant women were included during
the study period
**ESBL production was
concomitantly tested on the s
Mueller–Hinton agar plate, us
DDST method
Bebell et al.
(2017)
*Truly representative of febrile,
hypothermic, or normothermic post-
partum women in the hospital
**ESBL phenotype if synergy w
observed between AMC and C
CTX
AMC, amoxicillin–clavulanic acid; CASFM, Committé Antibiogramme  Société Français
test; ESBL, extended-spectrum beta-lactamase-producing; ESC, extended-spectrum cep
infection.
a Stars (*) represent the number of points awarded for the category; * = 1, ** = 2.participant selection, comparability, and outcome; each section
has a maximum number of ‘stars’ that can be awarded as a score (5,
2, and 3, respectively). For the overall quality assessment, the
maximum score is 10 stars. Studies with a minimum score of 3
were considered of acceptable methodological quality for inclu-
sion in the meta-analysis (Table 2).
Results
Geographic distribution of articles describing ESBL-E in women in
Africa
Ten observational studies were included for quantitative
analysis. These were from Nigeria (n = 3), Tanzania (n = 2),
Madagascar (n = 1), South Africa (n = 1), Mozambique (n = 1),
Uganda (n = 1), and Cameroon (n = 1). Six studies reported on
pregnant women and four on post-partum women. Three studies
reported ESBL-E isolates from urine, ﬁve others from stool, one
from vaginal swabs, and one from both urine and blood.ional studies).a
Comparability Exposure Overall
quality
assessment
score (out of a
maximum of
10)
Comparability of the groups on
the basis of design or analysis
Assessment of
outcome
with
L 
Study did not control for other
factors
*Independent blind
assessment
4
 with
L 
Study did not control for other
factors
*Independent blind
assessment
4
ed
st
Study did not control for other
factors
*Independent blind
assessment
4
sistant
ed by
*Study controlled for other
factors, multivariate analysis
*Independent blind
assessment
5
d with
ary
lates
Study did not control for other
factors
*Independent blind
assessment
3
ﬁed by
Z
Study did not control for other
factors
*Independent blind
assessment
3
disc
*Study controlled for other
factors, multivariate analysis
*Independent blind
assessment
5
uction
Study did not control for other
factors
*Independent blind
assessment
4
ame
ing the
*Study controlled for other
factors, multivariate analysis
*Independent blind
assessment
5
as
AZ or
The study design allowed a 4:1
ratio of normothermic to
febrile/hypothermic post-
partum women, but did not
control for other factors
**Record linkage and
the statistical test used
clearly described and
appropriate; p-value
presented
5
e de Microbiologie; CAZ, ceftazidime; CTX, cefotaxime; DDST, double disc synergy
halosporin; PMTCT, prevention of mother to child transmission; UTI, urinary tract
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Figure 2. Pooled proportion of ESBL-E in pregnant and post-partum women in Africa.
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in Africa
Through meta-analysis of the eligible studies, the overall
pooled estimate of the ESBL-E proportion in pregnant and post-
partum women in Africa was determined to be 0.17 (95% CI 0.10–
0.23) or 17% (95% CI 10–23%) (Figure 2). The heterogeneity was
high (I2 = 93.6%, p < 0.001).
The pooled proportion of ESBL-E in pregnant women was 0.22
(95% CI 0.12–0.31) (Figure 2) and that of ESBL-E in post-partum
women was 0.07 (95% CI 0.02–0.12). The pooled proportion of
ESBL-E in hospital settings was 0.14 (95% CI 0.05–0.23) compared
to 0.22 (95% CI 0.09–0.34) in community settings (Figure 3).
The pooled proportion of ESBL-E infections was 0.13 (95% CI
0.01–0.27) compared to 0.19 (95% CI 0.01–0.27) for ESBL-E
colonized pregnant and post-partum women (Figure 4).
Molecular epidemiology of ESBL-E colonization/infection
Chereau et al. (2015) (Madagascar) identiﬁed 66 ESBL-produc-
ing isolates in pregnant women, including E. coli (n = 46), Klebsiella
spp (n = 11), Enterobacter cloacae (n = 5), Citrobacter freundii (n = 3),
and Morganella morganii (n = 1). Forty-ﬁve isolates carried a blaCTX-
M gene, 15 carried blaSHV and blaCTX-M genes, and two carried a
blaSHV gene alone. No blaESBL gene and no cefoxitin resistance was
detected in four ESBL-producing E. coli isolates. Sáez-lópez et al.(2016) identiﬁed one ESBL-E isolate and it carried the CTX-M-15
gene. Kaba et al. (2016) reported that one mother–infant pair was
ESBL-positive at birth with SHV-5-producing E. cloacae. Djuikoue
et al. (2016a) reported that among 15 E. coli ESBL, all were CTX-M
group 1 (n = 15). Fortini et al. (2015) found E. coli (n = 32) producing
CTX-M-15.
Detection and conﬁrmation of ESBL in the laboratory: what methods
were used?
Five studies (Nelson et al., 2014; Olufunke et al., 2014; Aljabri
et al., 2010; Bebell et al., 2017; Tito et al., 2017), detected ESBL
production using the double disc synergy test (DDST). Chereau
et al. (2015), Djuikoue et al. (2016b), and Kaba et al. (2016) utilized
both synergy testing and molecular identiﬁcation of ESBL (PCR
sequencing). Sáez-lópez et al. (2016) and Fortini et al. (2015) used
molecular identiﬁcation of ESBL.
Factors associated with ESBL-E in pregnant women in Africa
Three studies included a multivariate analysis of risk factors for
ESBL-E colonization/infection among pregnant women. Chereau
et al. (2015) identiﬁed private indoor access to drinking water
(odds ratio (OR) 3.8, 95% CI 1.2–11.6) and living in an individual
house (OR 2.2, 95% CI 1.0–4.8) as independent risk factors for ESBL-
E colonization among Malagasy women (after adjusting for
Heterogene ity betw een grou ps:  p = 0.324
Overall  (I^2 = 93.59%,  p = 0.00 );
6
Subtotal  (I^2 = 93.52 %,  p = 0.00 )
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Figure 3. Pooled proportion of ESBL-E in women, Hospital vs Community settings.
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the detection of antimicrobial activity in the stool sample was the
only independent risk factor associated with ESBL E. coli carriage in
Cameroonian women (OR 5.4, 95% CI 2.0–14.7). Bebell et al. (2017))
identiﬁed single marital status (OR 2.6, 95% CI 1.1–6.1, p = 0.026),
low CD4+ count of <200/ml (OR 2.9, 95% CI 1.1–7.7, p = 0.031), and
current UTI symptoms (OR 2.5, 95% CI 1.1–6.0, p = 0.03) as
independent predictors of ESBL-E infection.
The following elements were not found to be signiﬁcantly
associated with ESBL-E colonization/infection in these three
studies: being employed or being a housewife (Tito et al. 2017),
drinking water supply from a spring or a well (Chereau et al., 2015),
and hospitalization in the last 3 months (Djuikoue et al. 2016a,b).
Discussion
The close relationship of the mother–infant pair represents a
potential risk for cross-transmission of maternal pathogens
leading to neonatal colonization or infection. Several studies have
conﬁrmed the role of maternal colonization in the subsequent
development of neonatal sepsis (particularly for group B Strepto-
coccus, but also for ESBL-E) (Chan et al., 2013; Kaba et al., 2016;
Denkel et al., 2014; Rettedal et al., 2015).
However, the scarcity of research on determinants of maternal
colonization in Africa is worrisome. This meta-analysis of eligible
published studies determined an overall pooled prevalence ofcolonization or infection with ESBL-E in pregnant and post-partum
women in Africa of 17% (95% CI 10–23%). This rate of colonization or
infection with ESBL-E is in line with a well-powered systematic
review conducted in Africa by Tansarli et al. (2014), who reported
proportions varying from 1.5% to 22.8% (pooled from 13 studies
with isolates from clinical urine samples) among patients either
infected or colonized with Enterobacteriaceae. However, these
proportions were not for pregnant and post-partum women as
speciﬁc groups. The pooled ESBL-E rate documented herein is
substantially higher than the rates found in high- and middle-
income countries, e.g., Norway (2.9%) (Rettedal et al., 2015) and
Argentina (5.4%) (Villar et al., 2013). Possible explanations for
increased ESBL-E carriage among African populations (both in
community (Pitout et al., 2005; Pallecchi et al., 2004) and hospital
settings) include poverty, suboptimal hygiene, contamination of
drinking water (faeces (Bain et al., 2014), antibiotics), water
sewage, communal toilets, easy access to antibiotics among
pregnant and post-partum women in Africa, and possibly also
increased use of antibiotics in livestock in Africa (Kariuki and
Dougan, 2014). Another possible explanation is that the lack of
trained healthcare workers (Kimang’a, 2012) and weak laboratory
and infection control capacity (Petti et al., 2006) may contribute to
healthcare-associated transmission of ESBL-E to pregnant and
post-partum women.
Another important ﬁnding is that the pooled proportion of
ESBL-E in community settings exceeded that in hospital settings
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Figure 4. Pooled proportion of ESBL-E in women by “infection or colonization” status.
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the high prevalence of ESBL-E in community isolates (58%) in the
Cameroonian study. However, another explanation may be the
effect of high-level ESBL-E contamination of community water and
food sources, lack of sanitation, and possibly overuse of antibiotics.
The apparent difference in ESBL-E proportions between commu-
nity and hospital settings could also be explained by the fact that
all included studies from the community only studied ESBL-E
colonization. In this meta-analysis, the proportion of ESBL-E
colonization was found to be greater than ESBL-E infection.
The detection of ESBL-E in samples from hospitalized pregnant
women with short lengths of stay may represent community-
acquired colonization and/or infection with ESBL-E. Because ESBL-
E stool carriage persists for a variable length of time (Ahmed et al.,
2014), the study population may have acquired ESBL-E during
pregnancy that then persisted up to delivery and the post-partum
period, reﬂecting community-acquired antimicrobial resistance
genes rather than healthcare-associated acquisition.
The pooled proportion of ESBL-E was higher among pregnant
women than post-partum women (22% vs. 7%) (Figure 2). This
difference may be explained by a greater probability of UTIs with
ESBL-E during pregnancy than in the post-partum period (Sáez-
lópez et al., 2016). It may also possibly represent differences in
asymptomatic bacteriuria during pregnancy, differences in antibi-
otic prescribing practices, and different decision-making when
choosing to send samples from pregnant vs. post-partum women
for culture.The clinical signiﬁcance of increased ESBL-E-associated UTI
during pregnancy is the potential for adverse pregnancy and
neonatal outcomes, including intrauterine growth restriction, low
birth weight, premature rupture of the membranes, foetal death,
and neonatal infections (Loh and Sivalingam., 2007; Romero et al.,
1989; Ovalle and Levancini, 2001; Matuszkiewicz-Rowinska et al.,
2015).
In this systematic review and meta-analysis, a few studies
attempted to report on factors associated with ESBL-E colonization
in women in Africa; however, the risk factors analysed varied from
one study to another and their pooled estimates could not be
produced. The molecular epidemiology of the ESBL-E enzymes
identiﬁed in the Madagascar (Chereau et al., 2015), Nigeria (Fortini
et al., 2015), Cameroon (Djuikoue et al., 2016b), and Mozambique
(Sáez-lópez et al., 2016) studies was in keeping with the global
predominance of the CTX-M clone, which is also widely reported in
community-acquired UTI (Pitout et al., 2005; Peirano and Pitout,
2010; Pallecchi et al., 2004; Livermore et al., 2007).
This systematic review has several strengths. A comprehensive
search of several electronic databases was performed, in addition
to manual searches and attempts to contact authors of relevant
studies to obtain speciﬁc details. The authors made an effort to
search the ‘grey literature’ by using Google Scholar, as many
African publications are not listed in PubMed or Scopus. This
appears to be the ﬁrst systematic review and meta-analysis on
ESBL-E colonization and/or infection focusing on pregnant and
post-partum women in Africa. This group is of particular
A.N.H. Bulabula et al. / International Journal of Infectious Diseases 64 (2017) 58–66 65importance for vertical transmission and subsequent neonatal
colonization and/or infection. Each study was thoroughly assessed
for risk of bias.
While informative, this systematic review and meta-analysis
has a number of limitations. The number of eligible studies was
small, demonstrating the apparent lack of studies on ESBL-E
colonization and infection in this population group: pregnant and
post-partum women in Africa. Given the limited sample size, the
ﬁndings of this systematic review and meta-analysis may not be
generalizable to all pregnant and/or post-partum women in Africa.
The publications retrieved and included in the meta-analysis were
all observational studies, a study type that is prone to many biases,
including selection and information biases (Archer and Horn,
2006).
More robust studies are needed to understand how frequently
pregnant and/or post-partum women become colonized or
infected with ESBL-E in Africa, as well as the related risk factors
in both community and hospital settings, to inform future
interventions to reduce their rates. Interventions could include
improved sanitation and water supplies, education of mothers on
personal hygiene, restriction of antibiotic use during pregnancy,
and strengthening of infection prevention in healthcare facilities.
Plain language summary
The level of colonization and/or infection with ESBL-E in
pregnant and post-partum women in Africa is higher than that
reported from high- and middle -income settings. In African
pregnant and post-partum women, the prevalence of ESBL-E in
community isolates exceeds that in hospital isolates. Maternal
ESBL-E colonization/infection represents a risk for mother to child
pathogen transmission with the potential for subsequent neonatal
colonization and/or infection.
Key recommendation
Further studies are needed to establish ESBL-E colonization and
infection rates amongst pregnant and post-partum women and
their determinants in all African regions. Interventions to reduce
ESBL-E colonization and carriage in Africa should focus on
preventing both community- and healthcare-associated ESBL-E
acquisition. Potential interventions could include the provision of
safe sanitation and clean water supplies, education of mothers on
personal hygiene, restricted use of antibiotics in pregnancy, and
strengthening of infection prevention efforts in healthcare
facilities (hand hygiene and appropriate disinfection of obstetric
equipment and the environment).
Research gaps
It is not well understood how frequently pregnant and post-
partum women become colonized and infected with ESBL-E, which
risk factors promote ESBL-E colonization/infection, and how this
could be prevented or managed, both in community and hospital
settings in Africa. In addition, health systems research is needed to
increase the understanding of the problem of antimicrobial
resistance in maternal and neonatal infections at the macro
(leadership or governance), meso (healthcare facilities and
programmes), and micro (pregnant women or service consumers)
levels.
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